SCHEMBL10128076

SCHEMBL10128076

Cc1cc(C)c2oc3c(-c4ccc(-c5nnc6c7ccccc7ccn56)cc4)cc(C)cc3c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.36
ALDH1A1 P00352 4/20 0.36
NUDT1 P36639 1/20 0.34
KDM4E B2RXH2 3/20 0.33
KMT2A Q03164 2/20 0.33
CSNK2A2 P19784 2/20 0.32
CSNK2B P67870 2/20 0.32
CSNK2A1 P68400 2/20 0.32
RXFP1 Q9HBX9 3/20 0.32
CYP1A2 P05177 2/20 0.31
CYP2A6 P11509 1/20 0.31
TP53 P04637 2/20 0.31
POLB P06746 2/20 0.31
HSD11B1 P28845 1/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
HSD17B10 Q99714 3/20 0.31
HPGD P15428 2/20 0.31
TSHR P16473 2/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128065 0.88 MAPT (0.38) MAPTALDH1A1NUDT1KDM4EKMT2A
SCHEMBL10128067 0.84 ALDH1A1 (0.36) MAPTALDH1A1KDM4EKMT2ARXFP1
SCHEMBL10128093 0.84 POLB (0.34) MAPTALDH1A1KDM4EKMT2ARXFP1
SCHEMBL10128121 0.83 MAPT (0.35) MAPTALDH1A1NUDT1KDM4EKMT2A
SCHEMBL10127912 0.81 MAPT (0.36) MAPTALDH1A1KDM4EKMT2ARXFP1
SCHEMBL10128088 0.80 PRKDC (0.37) MAPTALDH1A1KDM4ERXFP1TP53
SCHEMBL10128115 0.80 MAPT (0.39) MAPTALDH1A1KDM4EKMT2ACSNK2A2
SCHEMBL10148819 0.79 MAPT (0.34) MAPTALDH1A1KDM4EKMT2ACSNK2A2
SCHEMBL10128098 0.78 MAPT (0.34) MAPTALDH1A1KDM4EKMT2ACSNK2A2
SCHEMBL10128111 0.78 MAPT (0.33) MAPTALDH1A1KDM4EKMT2ACSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
WO-2012017842-A1 TRIAZOLE DERIVATIVE, HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-02-09 WO disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 MAPT 1271/4885ALDH1A1 1032/4885NUDT1 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.